Megakaryocytic Neoplasm — Trials

Megakaryocytic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

168 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 15
Ph III recruiting: 2
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (25)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05025488	Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm	active not recruiting	Phase 1	7	Marina KremyanskayaOTHER	1	Sep 28, 2026	clinicaltrials
NCT00392353	Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia	active not recruiting	Phase 1 / Phase 2	135	National Cancer Institute (NCI)NIH	1	Aug 7, 2026	clinicaltrials